Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for PRGO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 399.70M
March 31, 2026 357.20M
December 31, 2025 531.60M
September 30, 2025 432.10M
June 30, 2025 454.20M
March 31, 2025 409.90M
December 31, 2024 558.80M
September 30, 2024 1.464B
June 30, 2024 542.80M
March 31, 2024 658.50M
December 31, 2023 751.40M
September 30, 2023 598.40M
June 30, 2023 555.20M
March 31, 2023 553.10M
December 31, 2022 600.80M
September 30, 2022 468.90M
June 30, 2022 485.60M
March 31, 2022 1.966B
December 31, 2021 1.865B
September 30, 2021 2.080B
June 30, 2021 319.10M
March 31, 2021 473.80M
December 31, 2020 634.00M
September 30, 2020 852.70M
June 30, 2020 1.460B
Date Value
March 31, 2020 514.10M
December 31, 2019 360.90M
September 30, 2019 401.10M
June 30, 2019 1.058B
March 31, 2019 841.60M
December 31, 2018 560.50M
September 30, 2018 451.20M
June 30, 2018 526.50M
March 31, 2018 701.10M
December 31, 2017 695.70M
September 30, 2017 782.00M
June 30, 2017 774.40M
March 31, 2017 3.101B
December 31, 2016 660.50M
September 30, 2016 415.70M
June 30, 2016 681.80M
March 31, 2016 627.50M
December 31, 2015 417.80M
September 30, 2015 523.00M
June 30, 2015 798.30M
March 31, 2015 3.452B
June 30, 2014 805.40M
March 31, 2014 617.10M
December 31, 2013 606.60M
September 30, 2013 816.60M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Avadel Pharmaceuticals Plc 91.58M
Jazz Pharmaceuticals Plc 2.200B
GH Research Plc 362.65M
Cosmo NV --
Viatris, Inc. 1.410B